Yuseong, South Korea

Sang Koo Lee

This inventor holds 2 USPTO granted patents. Top assignee: Lg Life Sciences, Limited. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang Koo Lee. Retrieved from https://idiyas.com/inventor/sang-koo-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Yusong-gu, KR (2002)
  • Taejon, KR (2005)

Company Filing History:


Years Active: 2002-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Sang Koo Lee

Introduction

Sang Koo Lee is a notable inventor based in Yuseong, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. With a total of 2 patents to his name, his work has the potential to impact anticoagulant therapies.

Latest Patents

One of his latest patents involves piperidine and azetidine thrombin inhibitors. This invention relates to a compound having a specific formula and pharmaceutically acceptable salts thereof. The compounds of this formula and the pharmaceutical compositions containing them are classified as thrombin inhibitors, which are useful as anticoagulants.

Career Highlights

Sang Koo Lee is currently employed at LG Life Sciences, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new compounds that can enhance therapeutic options for patients requiring anticoagulation treatment.

Collaborations

He has collaborated with notable coworkers, including Won Hyuk Jung and Koo Lee, to advance research and development in his field.

Conclusion

Sang Koo Lee's contributions to thrombin inhibitors exemplify the importance of innovation in medicine. His work not only showcases his expertise but also highlights the collaborative efforts that drive advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…